Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 16 studies | 26% ± 10% | |
plasma cell | 11 studies | 31% ± 12% | |
epithelial cell | 9 studies | 34% ± 18% | |
endothelial cell | 8 studies | 21% ± 9% | |
ciliated cell | 8 studies | 34% ± 13% | |
macrophage | 8 studies | 23% ± 6% | |
myofibroblast cell | 7 studies | 19% ± 2% | |
connective tissue cell | 7 studies | 30% ± 10% | |
pericyte | 7 studies | 20% ± 5% | |
smooth muscle cell | 7 studies | 18% ± 2% | |
progenitor cell | 4 studies | 19% ± 2% | |
abnormal cell | 4 studies | 23% ± 6% | |
basal cell | 4 studies | 32% ± 14% | |
plasmablast | 3 studies | 47% ± 19% | |
pancreatic A cell | 3 studies | 40% ± 7% | |
hematopoietic precursor cell | 3 studies | 23% ± 9% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 22% ± 1% | |
neural crest cell | 3 studies | 18% ± 1% | |
IgG plasma cell | 3 studies | 18% ± 1% | |
oligodendrocyte precursor cell | 3 studies | 20% ± 4% | |
enteroendocrine cell | 3 studies | 29% ± 14% | |
intestinal crypt stem cell | 3 studies | 22% ± 3% | |
plasmacytoid dendritic cell | 3 studies | 22% ± 6% | |
neuron | 3 studies | 29% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3393.18 | 226 / 226 | 100% | 50.10 | 406 / 406 |
ovary | 100% | 3642.59 | 180 / 180 | 100% | 42.50 | 430 / 430 |
pancreas | 100% | 3978.08 | 328 / 328 | 100% | 49.46 | 178 / 178 |
skin | 100% | 3256.23 | 1809 / 1809 | 100% | 69.46 | 472 / 472 |
esophagus | 100% | 2008.18 | 1444 / 1445 | 100% | 34.82 | 183 / 183 |
brain | 100% | 2356.91 | 2640 / 2642 | 100% | 53.94 | 705 / 705 |
thymus | 100% | 3285.70 | 653 / 653 | 100% | 76.23 | 604 / 605 |
kidney | 100% | 3298.34 | 89 / 89 | 100% | 49.81 | 898 / 901 |
stomach | 100% | 2447.60 | 359 / 359 | 100% | 44.12 | 285 / 286 |
uterus | 100% | 2980.21 | 170 / 170 | 100% | 49.37 | 457 / 459 |
prostate | 100% | 3175.94 | 245 / 245 | 99% | 85.90 | 499 / 502 |
intestine | 100% | 2168.97 | 966 / 966 | 99% | 49.58 | 523 / 527 |
breast | 100% | 2686.32 | 459 / 459 | 99% | 53.35 | 1109 / 1118 |
lung | 100% | 2317.62 | 576 / 578 | 99% | 49.23 | 1149 / 1155 |
adrenal gland | 100% | 4059.74 | 258 / 258 | 99% | 48.20 | 228 / 230 |
bladder | 100% | 2546.71 | 21 / 21 | 98% | 46.23 | 494 / 504 |
adipose | 100% | 2525.03 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 83.20 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 35.99 | 29 / 29 |
spleen | 100% | 4955.47 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 39.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.86 | 1 / 1 |
blood vessel | 100% | 2590.07 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1263.56 | 793 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2295.10 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 86% | 1074.65 | 798 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_1900016 | Biological process | negative regulation of cytokine production involved in inflammatory response |
GO_0045087 | Biological process | innate immune response |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0005615 | Cellular component | extracellular space |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0005764 | Cellular component | lysosome |
GO_0012505 | Cellular component | endomembrane system |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0005770 | Cellular component | late endosome |
GO_0016020 | Cellular component | membrane |
GO_0005634 | Cellular component | nucleus |
GO_0070492 | Molecular function | oligosaccharide binding |
GO_0005515 | Molecular function | protein binding |
GO_0008061 | Molecular function | chitin binding |
Gene name | CHID1 |
Protein name | Chitinase domain-containing protein 1 Chitinase domain-containing protein 1 (Stabilin-1-interacting chitinase-like protein) (SI-CLP) Chitinase domain containing 1 |
Synonyms | GL008 SB139 PSEC0104 |
Description | FUNCTION: Saccharide- and LPS-binding protein with possible roles in pathogen sensing and endotoxin neutralization. Ligand-binding specificity relates to the length of the oligosaccharides, with preference for chitotetraose (in vitro). . FUNCTION: Saccharide- and LPS-binding protein with possible roles in pathogen sensing and endotoxin neutralization. Ligand-binding specificity relates to the length of the oligosaccharides, with preference for chitotetraose (in vitro). . FUNCTION: Saccharide- and LPS-binding protein with possible roles in pathogen sensing and endotoxin neutralization. Ligand-binding specificity relates to the length of the oligosaccharides, with preference for chitotetraose (in vitro). . FUNCTION: Saccharide- and LPS-binding protein with possible roles in pathogen sensing and endotoxin neutralization. Ligand-binding specificity relates to the length of the oligosaccharides, with preference for chitotetraose (in vitro). . FUNCTION: Saccharide- and LPS-binding protein with possible roles in pathogen sensing and endotoxin neutralization. Ligand-binding specificity relates to the length of the oligosaccharides, with preference for chitotetraose (in vitro). . FUNCTION: Saccharide- and LPS-binding protein with possible roles in pathogen sensing and endotoxin neutralization. Ligand-binding specificity relates to the length of the oligosaccharides, with preference for chitotetraose (in vitro). . FUNCTION: Saccharide- and LPS-binding protein with possible roles in pathogen sensing and endotoxin neutralization. Ligand-binding specificity relates to the length of the oligosaccharides, with preference for chitotetraose (in vitro). . FUNCTION: Saccharide- and LPS-binding protein with possible roles in pathogen sensing and endotoxin neutralization. Ligand-binding specificity relates to the length of the oligosaccharides, with preference for chitotetraose (in vitro). . FUNCTION: Saccharide- and LPS-binding protein with possible roles in pathogen sensing and endotoxin neutralization. Ligand-binding specificity relates to the length of the oligosaccharides, with preference for chitotetraose (in vitro). . |
Accessions | ENST00000534207.5 ENST00000533059.5 H0YC89 H0YDL6 ENST00000525840.1 E9PRL3 ENST00000429789.6 [Q9BWS9-3] E9PPA0 ENST00000528426.5 ENST00000449825.5 [Q9BWS9-1] ENST00000528581.5 [Q9BWS9-2] ENST00000525225.1 E9PJ91 ENST00000436108.6 [Q9BWS9-1] Q9BWS9 E9PJL0 ENST00000454838.6 [Q9BWS9-2] ENST00000532909.5 ENST00000323578.13 [Q9BWS9-1] E9PI70 ENST00000533056.5 E9PIP0 ENST00000534254.5 ENST00000528521.1 ENST00000530939.5 H0YEA3 E9PPH0 ENST00000528154.1 E9PQZ0 H0YCC4 ENST00000531859.5 ENST00000529539.5 E9PKF1 |